UniProt ID | PAPOA_HUMAN | |
---|---|---|
UniProt AC | P51003 | |
Protein Name | Poly(A) polymerase alpha | |
Gene Name | PAPOLA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 745 | |
Subcellular Localization | Cytoplasm. Nucleus. The 90 kDa form is nuclear while the 100 kDa and the 106 kDa forms are both nuclear and cytoplasmic. | |
Protein Description | Polymerase that creates the 3'-poly(A) tail of mRNA's. Also required for the endoribonucleolytic cleavage reaction at some polyadenylation sites. May acquire specificity through interaction with a cleavage and polyadenylation specificity factor (CPSF) at its C-terminus.. | |
Protein Sequence | MPFPVTTQGSQQTQPPQKHYGITSPISLAAPKETDCVLTQKLIETLKPFGVFEEEEELQRRILILGKLNNLVKEWIREISESKNLPQSVIENVGGKIFTFGSYRLGVHTKGADIDALCVAPRHVDRSDFFTSFYDKLKLQEEVKDLRAVEEAFVPVIKLCFDGIEIDILFARLALQTIPEDLDLRDDSLLKNLDIRCIRSLNGCRVTDEILHLVPNIDNFRLTLRAIKLWAKRHNIYSNILGFLGGVSWAMLVARTCQLYPNAIASTLVHKFFLVFSKWEWPNPVLLKQPEECNLNLPVWDPRVNPSDRYHLMPIITPAYPQQNSTYNVSVSTRMVMVEEFKQGLAITDEILLSKAEWSKLFEAPNFFQKYKHYIVLLASAPTEKQRLEWVGLVESKIRILVGSLEKNEFITLAHVNPQSFPAPKENPDKEEFRTMWVIGLVFKKTENSENLSVDLTYDIQSFTDTVYRQAINSKMFEVDMKIAAMHVKRKQLHQLLPNHVLQKKKKHSTEGVKLTALNDSSLDLSMDSDNSMSVPSPTSATKTSPLNSSGSSQGRNSPAPAVTAASVTNIQATEVSVPQVNSSESSGGTSSESIPQTATQPAISPPPKPTVSRVVSSTRLVNPPPRSSGNAATSGNAATKIPTPIVGVKRTSSPHKEESPKKTKTEEDETSEDANCLALSGHDKTEAKEQLDTETSTTQSETIQTAASLLASQKTSSTDLSDIPALPANPIPVIKNSIKLRLNR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MPFPVTTQGSQQT --CCCCCCCCCCCCC | 17.40 | 26074081 | |
7 | O-linked_Glycosylation | -MPFPVTTQGSQQTQ -CCCCCCCCCCCCCC | 31.03 | 28510447 | |
7 | Phosphorylation | -MPFPVTTQGSQQTQ -CCCCCCCCCCCCCC | 31.03 | 26074081 | |
10 | Phosphorylation | FPVTTQGSQQTQPPQ CCCCCCCCCCCCCCC | 14.86 | 26074081 | |
13 | Phosphorylation | TTQGSQQTQPPQKHY CCCCCCCCCCCCCCC | 35.09 | 26074081 | |
20 | Phosphorylation | TQPPQKHYGITSPIS CCCCCCCCCCCCCCC | 19.77 | 23927012 | |
23 | Phosphorylation | PQKHYGITSPISLAA CCCCCCCCCCCCCCC | 24.88 | 29255136 | |
24 | Phosphorylation | QKHYGITSPISLAAP CCCCCCCCCCCCCCC | 20.51 | 29255136 | |
27 | Phosphorylation | YGITSPISLAAPKET CCCCCCCCCCCCCCC | 18.49 | 23927012 | |
32 | Acetylation | PISLAAPKETDCVLT CCCCCCCCCCCCCHH | 69.40 | 26051181 | |
32 | Ubiquitination | PISLAAPKETDCVLT CCCCCCCCCCCCCHH | 69.40 | - | |
41 | Ubiquitination | TDCVLTQKLIETLKP CCCCHHHHHHHHHCC | 46.31 | - | |
47 | Ubiquitination | QKLIETLKPFGVFEE HHHHHHHCCCCCCCC | 45.80 | - | |
67 | Ubiquitination | RRILILGKLNNLVKE HHHHHHHHHHHHHHH | 44.59 | - | |
83 | Ubiquitination | IREISESKNLPQSVI HHHHHHCCCCCHHHH | 59.46 | - | |
88 | Phosphorylation | ESKNLPQSVIENVGG HCCCCCHHHHHHCCC | 24.11 | 20068231 | |
99 | Phosphorylation | NVGGKIFTFGSYRLG HCCCEEEEECCEECC | 30.47 | 20068231 | |
102 | Phosphorylation | GKIFTFGSYRLGVHT CEEEEECCEECCCCC | 11.68 | 20068231 | |
103 | Phosphorylation | KIFTFGSYRLGVHTK EEEEECCEECCCCCC | 15.38 | 20068231 | |
109 | Phosphorylation | SYRLGVHTKGADIDA CEECCCCCCCCCCCE | 28.85 | 27422710 | |
110 | Ubiquitination | YRLGVHTKGADIDAL EECCCCCCCCCCCEE | 36.90 | - | |
118 | Glutathionylation | GADIDALCVAPRHVD CCCCCEEEECCCCCC | 2.35 | 22555962 | |
136 | Ubiquitination | FFTSFYDKLKLQEEV HHHHHHHHHHHHHHH | 35.82 | 21890473 | |
136 (in isoform 2) | Ubiquitination | - | 35.82 | 21890473 | |
138 | Ubiquitination | TSFYDKLKLQEEVKD HHHHHHHHHHHHHHH | 54.59 | - | |
144 | Acetylation | LKLQEEVKDLRAVEE HHHHHHHHHHHHHHH | 55.09 | 25953088 | |
144 | Ubiquitination | LKLQEEVKDLRAVEE HHHHHHHHHHHHHHH | 55.09 | - | |
144 (in isoform 2) | Ubiquitination | - | 55.09 | 21890473 | |
152 (in isoform 1) | Ubiquitination | - | 9.38 | 21890473 | |
160 (in isoform 1) | Ubiquitination | - | 2.19 | 21890473 | |
188 | Phosphorylation | DLDLRDDSLLKNLDI CCCCCCCHHHHCCCH | 39.63 | 24719451 | |
191 | Ubiquitination | LRDDSLLKNLDIRCI CCCCHHHHCCCHHHH | 61.84 | - | |
191 (in isoform 2) | Ubiquitination | - | 61.84 | 21890473 | |
207 (in isoform 1) | Ubiquitination | - | 14.46 | 21890473 | |
307 | Phosphorylation | WDPRVNPSDRYHLMP CCCCCCHHHCCCCCE | 29.53 | 24275569 | |
310 | Phosphorylation | RVNPSDRYHLMPIIT CCCHHHCCCCCEEEC | 12.33 | - | |
317 | Phosphorylation | YHLMPIITPAYPQQN CCCCEEECCCCCCCC | 11.55 | 23403867 | |
355 | Ubiquitination | TDEILLSKAEWSKLF CHHHHCCHHHHHHHH | 50.74 | - | |
360 | Ubiquitination | LSKAEWSKLFEAPNF CCHHHHHHHHHCCCH | 59.26 | 21890473 | |
370 | Ubiquitination | EAPNFFQKYKHYIVL HCCCHHHHCCEEEEE | 51.62 | - | |
372 | Ubiquitination | PNFFQKYKHYIVLLA CCHHHHCCEEEEEEE | 36.65 | - | |
376 (in isoform 1) | Ubiquitination | - | 2.56 | 21890473 | |
380 | Phosphorylation | HYIVLLASAPTEKQR EEEEEEEECCCHHHH | 34.45 | - | |
444 | Sumoylation | WVIGLVFKKTENSEN HHHEEEEECCCCCCC | 51.83 | - | |
444 | Sumoylation | WVIGLVFKKTENSEN HHHEEEEECCCCCCC | 51.83 | - | |
445 | Sumoylation | VIGLVFKKTENSENL HHEEEEECCCCCCCE | 50.00 | - | |
445 | Sumoylation | VIGLVFKKTENSENL HHEEEEECCCCCCCE | 50.00 | - | |
474 | Phosphorylation | VYRQAINSKMFEVDM HHHHHHHCCHHHHHH | 21.27 | 28851738 | |
482 | Acetylation | KMFEVDMKIAAMHVK CHHHHHHHHHHHHHC | 25.40 | 15611779 | |
486 | Sulfoxidation | VDMKIAAMHVKRKQL HHHHHHHHHHCHHHH | 2.49 | 30846556 | |
489 | Acetylation | KIAAMHVKRKQLHQL HHHHHHHCHHHHHHH | 38.92 | 25953088 | |
509 | Phosphorylation | LQKKKKHSTEGVKLT HHCCCCCCCCCCEEE | 36.71 | 30576142 | |
510 | Phosphorylation | QKKKKHSTEGVKLTA HCCCCCCCCCCEEEE | 36.16 | 20068231 | |
516 | Phosphorylation | STEGVKLTALNDSSL CCCCCEEEECCCCCC | 24.31 | 20873877 | |
521 | Phosphorylation | KLTALNDSSLDLSMD EEEECCCCCCCCCCC | 31.56 | 20873877 | |
522 | Phosphorylation | LTALNDSSLDLSMDS EEECCCCCCCCCCCC | 28.85 | 25137130 | |
526 | Phosphorylation | NDSSLDLSMDSDNSM CCCCCCCCCCCCCCC | 21.88 | 30278072 | |
529 | Phosphorylation | SLDLSMDSDNSMSVP CCCCCCCCCCCCCCC | 30.01 | 30278072 | |
532 | Phosphorylation | LSMDSDNSMSVPSPT CCCCCCCCCCCCCCC | 19.88 | 20873877 | |
534 | Phosphorylation | MDSDNSMSVPSPTSA CCCCCCCCCCCCCCC | 30.60 | 30278072 | |
537 | Phosphorylation | DNSMSVPSPTSATKT CCCCCCCCCCCCCCC | 38.36 | 30278072 | |
539 | Phosphorylation | SMSVPSPTSATKTSP CCCCCCCCCCCCCCC | 35.02 | 30278072 | |
540 | Phosphorylation | MSVPSPTSATKTSPL CCCCCCCCCCCCCCC | 37.01 | 30278072 | |
542 | Phosphorylation | VPSPTSATKTSPLNS CCCCCCCCCCCCCCC | 34.32 | 30278072 | |
544 | Phosphorylation | SPTSATKTSPLNSSG CCCCCCCCCCCCCCC | 31.08 | 30278072 | |
545 | Phosphorylation | PTSATKTSPLNSSGS CCCCCCCCCCCCCCC | 29.01 | 21955146 | |
549 | Phosphorylation | TKTSPLNSSGSSQGR CCCCCCCCCCCCCCC | 43.70 | 28450419 | |
550 | Phosphorylation | KTSPLNSSGSSQGRN CCCCCCCCCCCCCCC | 41.44 | 28450419 | |
552 | Phosphorylation | SPLNSSGSSQGRNSP CCCCCCCCCCCCCCC | 22.80 | 28450419 | |
553 | Phosphorylation | PLNSSGSSQGRNSPA CCCCCCCCCCCCCCC | 39.93 | 23927012 | |
558 | Phosphorylation | GSSQGRNSPAPAVTA CCCCCCCCCCCCCEE | 22.52 | 25332170 | |
569 | Phosphorylation | AVTAASVTNIQATEV CCEEEEEEEEEEEEE | 24.90 | 24275569 | |
586 | Phosphorylation | PQVNSSESSGGTSSE CCCCCCCCCCCCCCC | 35.91 | 25332170 | |
605 | Phosphorylation | TATQPAISPPPKPTV CCCCCCCCCCCCCCC | 33.20 | 24719451 | |
617 | Phosphorylation | PTVSRVVSSTRLVNP CCCEEEEECCEECCC | 24.12 | 22199227 | |
618 | Phosphorylation | TVSRVVSSTRLVNPP CCEEEEECCEECCCC | 13.11 | 26699800 | |
619 | Phosphorylation | VSRVVSSTRLVNPPP CEEEEECCEECCCCC | 22.10 | 27273156 | |
628 | Phosphorylation | LVNPPPRSSGNAATS ECCCCCCCCCCCCCC | 48.66 | 29116813 | |
629 | Phosphorylation | VNPPPRSSGNAATSG CCCCCCCCCCCCCCC | 37.03 | 29116813 | |
634 | Phosphorylation | RSSGNAATSGNAATK CCCCCCCCCCCCCCC | 34.45 | 29116813 | |
635 | Phosphorylation | SSGNAATSGNAATKI CCCCCCCCCCCCCCC | 25.89 | 29116813 | |
640 | Phosphorylation | ATSGNAATKIPTPIV CCCCCCCCCCCCCCE | 27.39 | 23312004 | |
641 | Acetylation | TSGNAATKIPTPIVG CCCCCCCCCCCCCEE | 41.80 | 25953088 | |
644 | Phosphorylation | NAATKIPTPIVGVKR CCCCCCCCCCEEEEC | 29.17 | 22985185 | |
650 | Acetylation | PTPIVGVKRTSSPHK CCCCEEEECCCCCCC | 43.99 | 23954790 | |
652 | Phosphorylation | PIVGVKRTSSPHKEE CCEEEECCCCCCCCC | 28.04 | 28176443 | |
653 | Phosphorylation | IVGVKRTSSPHKEES CEEEECCCCCCCCCC | 46.00 | 28176443 | |
654 | Phosphorylation | VGVKRTSSPHKEESP EEEECCCCCCCCCCC | 30.34 | 28176443 | |
660 | Phosphorylation | SSPHKEESPKKTKTE CCCCCCCCCCCCCCC | 43.01 | 26055452 | |
662 | Sumoylation | PHKEESPKKTKTEED CCCCCCCCCCCCCCC | 80.50 | - | |
662 | Sumoylation | PHKEESPKKTKTEED CCCCCCCCCCCCCCC | 80.50 | - | |
663 | Sumoylation | HKEESPKKTKTEEDE CCCCCCCCCCCCCCC | 59.65 | - | |
663 | Sumoylation | HKEESPKKTKTEEDE CCCCCCCCCCCCCCC | 59.65 | - | |
664 | Phosphorylation | KEESPKKTKTEEDET CCCCCCCCCCCCCCC | 49.69 | 28450419 | |
666 | Phosphorylation | ESPKKTKTEEDETSE CCCCCCCCCCCCCCC | 50.25 | 30576142 | |
671 | Phosphorylation | TKTEEDETSEDANCL CCCCCCCCCCHHCCC | 50.14 | 25849741 | |
672 | Phosphorylation | KTEEDETSEDANCLA CCCCCCCCCHHCCCH | 31.28 | 30108239 | |
681 | Phosphorylation | DANCLALSGHDKTEA HHCCCHHCCCCHHHH | 28.60 | 30108239 | |
685 | Acetylation | LALSGHDKTEAKEQL CHHCCCCHHHHHHHH | 42.46 | 26051181 | |
686 | Phosphorylation | ALSGHDKTEAKEQLD HHCCCCHHHHHHHHC | 47.43 | 30108239 | |
698 | O-linked_Glycosylation | QLDTETSTTQSETIQ HHCCCCCCCHHHHHH | 35.95 | 28510447 | |
699 | O-linked_Glycosylation | LDTETSTTQSETIQT HCCCCCCCHHHHHHH | 29.84 | 28510447 | |
701 | O-linked_Glycosylation | TETSTTQSETIQTAA CCCCCCHHHHHHHHH | 34.32 | 28510447 | |
713 | Phosphorylation | TAASLLASQKTSSTD HHHHHHHCCCCCCCC | 31.98 | - | |
716 | Phosphorylation | SLLASQKTSSTDLSD HHHHCCCCCCCCHHH | 21.92 | 26846344 | |
717 | Phosphorylation | LLASQKTSSTDLSDI HHHCCCCCCCCHHHC | 37.97 | 26846344 | |
718 | Phosphorylation | LASQKTSSTDLSDIP HHCCCCCCCCHHHCC | 31.04 | 26846344 | |
719 | Phosphorylation | ASQKTSSTDLSDIPA HCCCCCCCCHHHCCC | 40.50 | 26846344 | |
722 | Phosphorylation | KTSSTDLSDIPALPA CCCCCCHHHCCCCCC | 35.98 | 26846344 | |
736 | Acetylation | ANPIPVIKNSIKLRL CCCCCCCCCEEEEEC | 44.89 | 17172643 | |
738 | Phosphorylation | PIPVIKNSIKLRLNR CCCCCCCEEEEECCC | 18.99 | 23401153 | |
740 | Acetylation | PVIKNSIKLRLNR-- CCCCCEEEEECCC-- | 27.63 | 17172643 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PAPOA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PAPOA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PAPOA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HDAC1_HUMAN | HDAC1 | physical | 17172643 | |
HDAC3_HUMAN | HDAC3 | physical | 17172643 | |
HDA10_HUMAN | HDAC10 | physical | 17172643 | |
SIR1_HUMAN | SIRT1 | physical | 17172643 | |
SIR2_HUMAN | SIRT2 | physical | 17172643 | |
CPSF6_HUMAN | CPSF6 | physical | 17172643 | |
CPSF5_HUMAN | NUDT21 | physical | 17172643 | |
IMB1_HUMAN | KPNB1 | physical | 17172643 | |
PP1B_HUMAN | PPP1CB | physical | 22939629 | |
GNA11_HUMAN | GNA11 | physical | 26186194 | |
ARBK1_HUMAN | ADRBK1 | physical | 26344197 | |
CSTF2_HUMAN | CSTF2 | physical | 26344197 | |
CSTFT_HUMAN | CSTF2T | physical | 26344197 | |
CSTF3_HUMAN | CSTF3 | physical | 26344197 | |
ROA1_HUMAN | HNRNPA1 | physical | 26344197 | |
SPT5H_HUMAN | SUPT5H | physical | 26344197 | |
CIRBP_HUMAN | CIRBP | physical | 26496610 | |
RSRC1_HUMAN | RSRC1 | physical | 26496610 | |
RASN_HUMAN | NRAS | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-534 AND SER-537, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-553, AND MASSSPECTROMETRY. |